NEWS & More

THE LATEST NEWS AND EVENTS

Aitia and G3 Therapeutics Publish Results Identifying New Causal Biomarkers of Atherosclerotic Coronary Artery Disease (ASCAD), the Leading Cause of Morbidity and Mortality Worldwide

GNS Rebrands as Aitia to Focus on AI-Enabled Drug Discovery

GNS Announces Abstract and Oral Poster Presentation at CTAD & ASH, 2022 Annual Conferences

GNS Appoints John Maraganore as Chair of the Board

GNS and Servier Announce AI Collaboration to Advance Multiple Myeloma Drug Discovery and Clinical Development

GNS Appoints John Maraganore, PhD, as Strategic Advisor

GNS and the Global Alzheimer’s Platform Foundation® Partner to advance Alzheimer’s R&D

GNS Healthcare and Arvinas Enter into Neuroscience Drug Discovery Collaboration

GNS Healthcare Hires Industry Veteran, Joseph F. Donahue, as Chief Business Officer

GNS Healthcare and Scipher Medicine® Collaborate to Develop World’s First in silico Patient for Rheumatoid Arthritis